Tumor-specific immunity induced by cryoablation in a murine renal cell carcinoma model

Hyung Keun Kim, Jong Hyun Pyun, Seok Cho, Sung-Gu Kang, Jeong Gu Lee, Je-Jong Kim, Jun Cheon, Hong Seok Park, Seok Ho Kang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: To evaluate tumor-specific immunity and define the mechanisms involved in the cryoimmunologic response, we compared the tumor control efficacy and immunologic responses of cryoablation with those of surgical excision in a tumor rechallenge model.

Materials and Methods: Sixty BALB/c mice with RENCA tumors that were generated in the left flank area underwent cryoablation or radical excision. The mice successfully treated were rechallenged with RENCA or an undifferentiated colon carcinoma cell line, CT26, in the contralateral right flank area. The recurrence rate after tumor rechallenge in each group was then observed. To assess the immunologic response of each treatment modality, fluorescent-activated cell sorting (FACS) analysis and a cytotoxicity assay using 51Cr release were performed.

Results: After reinoculation of the RENCA cells, the rate of tumor growth was significantly higher in the surgical excision group than in the cryoablation group (94.4% vs. 11.1%, p=0.001). In the cryoablation group, the tumor growth rate was significantly increased after rechallenge of CT26 cells compared with RENCA (94.1% vs. 11.1%, p=0.001). The cryoablation group showed an elevated CD3, CD4, CD8 T, and natural killer cell count in the FACS analysis and also showed significantly increased cytotoxicity in the 51Cr release assay compared with the excision group.

Conclusions: These results showed that cryoablation, compared to surgical resection, was more effective in preventing tumor growth after rechallenge with RENCA cells and that this response was tumor-specific, because the CT26 cells did not have the same effect.

Original languageEnglish
Pages (from-to)834-840
Number of pages7
JournalKorean Journal of Urology
Volume55
Issue number12
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Cryosurgery
Renal Cell Carcinoma
Immunity
Neoplasms
Growth
Colon
Cell Count
Carcinoma
Recurrence
Cell Line

Keywords

  • Animal models
  • Cryosurgery
  • Immunity
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Urology

Cite this

Tumor-specific immunity induced by cryoablation in a murine renal cell carcinoma model. / Kim, Hyung Keun; Pyun, Jong Hyun; Cho, Seok; Kang, Sung-Gu; Lee, Jeong Gu; Kim, Je-Jong; Cheon, Jun; Park, Hong Seok; Kang, Seok Ho.

In: Korean Journal of Urology, Vol. 55, No. 12, 01.01.2014, p. 834-840.

Research output: Contribution to journalArticle

@article{a063f1763aab464f89eeee44705a8f2a,
title = "Tumor-specific immunity induced by cryoablation in a murine renal cell carcinoma model",
abstract = "Purpose: To evaluate tumor-specific immunity and define the mechanisms involved in the cryoimmunologic response, we compared the tumor control efficacy and immunologic responses of cryoablation with those of surgical excision in a tumor rechallenge model.Materials and Methods: Sixty BALB/c mice with RENCA tumors that were generated in the left flank area underwent cryoablation or radical excision. The mice successfully treated were rechallenged with RENCA or an undifferentiated colon carcinoma cell line, CT26, in the contralateral right flank area. The recurrence rate after tumor rechallenge in each group was then observed. To assess the immunologic response of each treatment modality, fluorescent-activated cell sorting (FACS) analysis and a cytotoxicity assay using 51Cr release were performed.Results: After reinoculation of the RENCA cells, the rate of tumor growth was significantly higher in the surgical excision group than in the cryoablation group (94.4{\%} vs. 11.1{\%}, p=0.001). In the cryoablation group, the tumor growth rate was significantly increased after rechallenge of CT26 cells compared with RENCA (94.1{\%} vs. 11.1{\%}, p=0.001). The cryoablation group showed an elevated CD3, CD4, CD8 T, and natural killer cell count in the FACS analysis and also showed significantly increased cytotoxicity in the 51Cr release assay compared with the excision group.Conclusions: These results showed that cryoablation, compared to surgical resection, was more effective in preventing tumor growth after rechallenge with RENCA cells and that this response was tumor-specific, because the CT26 cells did not have the same effect.",
keywords = "Animal models, Cryosurgery, Immunity, Renal cell carcinoma",
author = "Kim, {Hyung Keun} and Pyun, {Jong Hyun} and Seok Cho and Sung-Gu Kang and Lee, {Jeong Gu} and Je-Jong Kim and Jun Cheon and Park, {Hong Seok} and Kang, {Seok Ho}",
year = "2014",
month = "1",
day = "1",
doi = "10.4111/kju.2014.55.12.834",
language = "English",
volume = "55",
pages = "834--840",
journal = "Korean Journal of Urology",
issn = "2005-6737",
publisher = "Korean Urological Association",
number = "12",

}

TY - JOUR

T1 - Tumor-specific immunity induced by cryoablation in a murine renal cell carcinoma model

AU - Kim, Hyung Keun

AU - Pyun, Jong Hyun

AU - Cho, Seok

AU - Kang, Sung-Gu

AU - Lee, Jeong Gu

AU - Kim, Je-Jong

AU - Cheon, Jun

AU - Park, Hong Seok

AU - Kang, Seok Ho

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Purpose: To evaluate tumor-specific immunity and define the mechanisms involved in the cryoimmunologic response, we compared the tumor control efficacy and immunologic responses of cryoablation with those of surgical excision in a tumor rechallenge model.Materials and Methods: Sixty BALB/c mice with RENCA tumors that were generated in the left flank area underwent cryoablation or radical excision. The mice successfully treated were rechallenged with RENCA or an undifferentiated colon carcinoma cell line, CT26, in the contralateral right flank area. The recurrence rate after tumor rechallenge in each group was then observed. To assess the immunologic response of each treatment modality, fluorescent-activated cell sorting (FACS) analysis and a cytotoxicity assay using 51Cr release were performed.Results: After reinoculation of the RENCA cells, the rate of tumor growth was significantly higher in the surgical excision group than in the cryoablation group (94.4% vs. 11.1%, p=0.001). In the cryoablation group, the tumor growth rate was significantly increased after rechallenge of CT26 cells compared with RENCA (94.1% vs. 11.1%, p=0.001). The cryoablation group showed an elevated CD3, CD4, CD8 T, and natural killer cell count in the FACS analysis and also showed significantly increased cytotoxicity in the 51Cr release assay compared with the excision group.Conclusions: These results showed that cryoablation, compared to surgical resection, was more effective in preventing tumor growth after rechallenge with RENCA cells and that this response was tumor-specific, because the CT26 cells did not have the same effect.

AB - Purpose: To evaluate tumor-specific immunity and define the mechanisms involved in the cryoimmunologic response, we compared the tumor control efficacy and immunologic responses of cryoablation with those of surgical excision in a tumor rechallenge model.Materials and Methods: Sixty BALB/c mice with RENCA tumors that were generated in the left flank area underwent cryoablation or radical excision. The mice successfully treated were rechallenged with RENCA or an undifferentiated colon carcinoma cell line, CT26, in the contralateral right flank area. The recurrence rate after tumor rechallenge in each group was then observed. To assess the immunologic response of each treatment modality, fluorescent-activated cell sorting (FACS) analysis and a cytotoxicity assay using 51Cr release were performed.Results: After reinoculation of the RENCA cells, the rate of tumor growth was significantly higher in the surgical excision group than in the cryoablation group (94.4% vs. 11.1%, p=0.001). In the cryoablation group, the tumor growth rate was significantly increased after rechallenge of CT26 cells compared with RENCA (94.1% vs. 11.1%, p=0.001). The cryoablation group showed an elevated CD3, CD4, CD8 T, and natural killer cell count in the FACS analysis and also showed significantly increased cytotoxicity in the 51Cr release assay compared with the excision group.Conclusions: These results showed that cryoablation, compared to surgical resection, was more effective in preventing tumor growth after rechallenge with RENCA cells and that this response was tumor-specific, because the CT26 cells did not have the same effect.

KW - Animal models

KW - Cryosurgery

KW - Immunity

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84916605650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84916605650&partnerID=8YFLogxK

U2 - 10.4111/kju.2014.55.12.834

DO - 10.4111/kju.2014.55.12.834

M3 - Article

VL - 55

SP - 834

EP - 840

JO - Korean Journal of Urology

JF - Korean Journal of Urology

SN - 2005-6737

IS - 12

ER -